Most Read Articles
Audrey Abella, 15 May 2020
In adults with atrial fibrillation (AF) after percutaneous coronary intervention (PCI), dual therapy (direct oral anticoagulant [DOAC] + P2Y12 inhibitor) reduces the risk of bleeding compared with triple therapy (vitamin K antagonist [VKA] + DAPT* [aspirin and P2Y12 inhibitor]), a meta-analysis has shown. However, its effects on the risks of mortality and ischaemic endpoints** remain unclear.
09 May 2020
Use of aspirin during the implantation window of the menstrual cycle appears to increase fecundability, reveals a recent study.
Rachel Soon, 08 Apr 2020

Guidelines for local pharmacists on what actions to take during the COVID-19 pandemic have been issued by the Malaysian Pharmaceutical Society (MPS).

Pearl Toh, 11 Jun 2019
The novel antibody-drug conjugate enfortumab vedotin showed promising clinical activity in patients with advanced and metastatic urothelial cancer for whom there is a high unmet need, according to the EV-201 study presented at the ASCO 2019 Meeting.

Anaemia linked to out-of-range INR in patients taking warfarin

20 Oct 2019

Younger, female patients prescribed warfarin are more likely to present with in-clinic anaemia, and these patients are at risk for out-of-range international normalized ratio (INR), suggests a recent study.

“Pharmacists practicing in anticoagulation clinics can incorporate this information into patient care practice in efforts to maintain optimal management,” the authors suggested.

This retrospective chart review sought to explore the relationship between in-clinic anaemia and the control of INR within an anticoagulation clinic. A random sample of patients seen in an academic medical centre pharmacy-managed anticoagulation clinic was enrolled in this study.

The authors used the Hemochron Signature Elite machine to monitor point-of-care INR. They also carried out statistical analyses with the use of the web-based platform STATA MP (https://www.stata.com/statamp/).

In-clinic anaemia was defined as haematocrit <32 percent.

A total of 300 patients were included in the analysis, of whom 45 (15 percent) had in-clinic anaemia. Patients with in-clinic anaemia were more likely to be younger (p<0.05), female (p<0.05), and have a diagnosis of sickle cell disease or anaemia (p<0.05).

Of note, patients diagnosed with in-clinic anaemia were shown to be at increased risk of having out-of-range INR (odds ratio, 0.52, 95 percent CI, 0.27–0.98) in the unadjusted logistic regression model. In addition, no significance was seen in the adjusted regression model.

“Many factors influence INR,” according to the authors. “[H]owever, few studies have examined the impact of anaemia in warfarin patients.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Audrey Abella, 15 May 2020
In adults with atrial fibrillation (AF) after percutaneous coronary intervention (PCI), dual therapy (direct oral anticoagulant [DOAC] + P2Y12 inhibitor) reduces the risk of bleeding compared with triple therapy (vitamin K antagonist [VKA] + DAPT* [aspirin and P2Y12 inhibitor]), a meta-analysis has shown. However, its effects on the risks of mortality and ischaemic endpoints** remain unclear.
09 May 2020
Use of aspirin during the implantation window of the menstrual cycle appears to increase fecundability, reveals a recent study.
Rachel Soon, 08 Apr 2020

Guidelines for local pharmacists on what actions to take during the COVID-19 pandemic have been issued by the Malaysian Pharmaceutical Society (MPS).

Pearl Toh, 11 Jun 2019
The novel antibody-drug conjugate enfortumab vedotin showed promising clinical activity in patients with advanced and metastatic urothelial cancer for whom there is a high unmet need, according to the EV-201 study presented at the ASCO 2019 Meeting.